Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now
Quote Panel
Key Metrics
Fundamentals
Relative Strength
688289.SS
Sector
Top 5 RS in Group
Symbol | Company | RS | 5-Day Perf. |
|---|---|---|---|
Forecast
Analyst rating
Last analyst upgrade/downgrade
Earnings Growth
YoY
Current
Estimates
Q4.22
-29%
0.58
vs 0.82
Q1.23
-91%
0.1
vs 1.11
Q2.23
-93%
0.05
vs 0.81
Q3.23
-55%
0.36
vs 0.81
Q4.23
-81%
0.11
vs 0.58
Q1.24
+36%
0.14
vs 0.1
Q2.24
+141%
0.13
vs 0.05
Q3.24
-81%
0.07
vs 0.36
Q4.24
+50%
0.17
vs 0.11
Q1.25
+13%
0.16
vs 0.14
Sales Growth
YoY
Current
Estimates
Q4.22
+91%
2.4B vs 1.2B
Q1.23
-86%
195.2M vs 1.4B
Q2.23
-81%
232.5M vs 1.3B
Q3.23
-85%
204.8M vs 1.4B
Q4.23
-84%
371.7M vs 2.4B
Q1.24
+99%
388.6M vs 195.2M
Q2.24
+39%
323.5M vs 232.5M
Q3.24
+54%
315.6M vs 204.8M
Q4.24
+25%
464M vs 371.7M
Q1.25
+22%
475.5M vs 388.6M
Return on Equity
QoQ
Q2.23
+0%
0
vs 0.01
Q3.23
+3%
0.03
vs 0
Q4.23
+1%
0.01
vs 0.03
Q1.24
+1%
0.01
vs 0.01
Q2.24
+1%
0.01
vs 0.01
Q3.24
+1%
0.01
vs 0.01
Q4.24
+1%
0.01
vs 0.01
Q1.25
+1%
0.01
vs 0.01
Institutionnal Ownership
Forecast
432%2026-Revenue
448%2026-EPS
1096%2026-EBITDA
Analyst rating
Strong Sell
Sell
Buy
Neutral
Strong Buy
Price Target
NaN(-100.00%)
Number of analyst
Last analyst upgrade/downgrade
No Data Available
Relative Strength
688289.SS
Sector
Top 5 RS in Group
Symbol | Company | RS | 5-Day Perf. |
|---|---|---|---|
Quote Panel
Key Metrics
Sansure Biotech Inc. develops and sells upstream nucleic acid extraction kits, real time PCR diagnostic and research kits, and fluorescence systems in China and internationally. The company offers novel coronavirus nucleic acid diagnostic kits; viral hepatitis and AIDS, blood screening, and extraction kits; cancer-related biomarkers; and kits for respiratory tract diseases, STDs, digestive tract diseases, prenatal and postnatal care, and genetic diseases, as well as instruments and other consumables. It serves hospitals and laboratories. The company was founded in 2008 and is based in Changsha, China.
SHH
0.17Â ( 0.83%)
Relative Strenght
Volume Buzz
51%
Earning Acce
Yes
Dist 52w H.
22%Fundamentals
P/E Ratio
P/S Ratio
P/B Ratio
Debt/Equity
Net Margin
EPS
How 688289.SS compares to sector?